Protein kinase Mζ in medial prefrontal cortex mediates depressive
C Yang,H-L Guo,J Shi,J-F Liu,J-S Wang,K Yuan,L Lu,W Yan,W Zhang,W-H Chen,W-L Zhu,Y Han,Y-N Ma,Y-X Luo,Y-X Xue
DOI: https://doi.org/10.1038/mp.2017.219
IF: 11
2018-01-01
Molecular Psychiatry
Abstract:Neuronal atrophy and alterations of synaptic structure and function in the medial prefrontal cortex (mPFC) have been implicated in the pathogenesis of depression, but the underlying molecular mechanisms are largely unknown. The protein kinase M. (PKM.), a brain-specific atypical protein kinase C isoform, is important for maintaining long-term potentiation and storing memory. In the present study, we explored the role of PKM. in mPFC in two rat models of depression, chronic unpredictable stress (CUS) and learned helplessness. The involvement of PKM. in the antidepressant effects of conventional antidepressants and ketamine were also investigated. We found that chronic stress decreased the expression of PKM. in the mPFC and hippocampus but not in the orbitofrontal cortex. Overexpression of PKM. in mPFC prevented the depressive-like and anxiety-like behaviors induced by CUS, and reversed helplessness behaviors. Inhibition of PKM. in mPFC by expressing a PKM. dominant-negative mutant induced depressive-like behaviors after subthreshold unpredictable stress and increased learned helplessness behavior. Furthermore, stressinduced deficits in synaptic proteins and decreases in dendritic density and the frequency of miniature excitatory postsynaptic currents in the mPFC were prevented by PKM. overexpression and potentiated by PKM. inhibition in subthreshold stress rats. The antidepressants fluoxetine, desipramine and ketamine increased PKM. expression in mPFC and PKM. mediated the antidepressant effects of ketamine. These findings identify PKM. in mPFC as a critical mediator of depressive-like behavior and antidepressant response, providing a potential therapeutic target in developing novel antidepressants.